| Baseline | Intervention | Week 12 | Week 24 | Week 52 |
---|---|---|---|---|---|
Time (months) | −1 | 1-3 | 3 | 6 | 12 |
Primary outcome variable | Â | Â | Â | Â | Â |
FIQRa | x | x | x | x | x |
Secondary outcome variables | Â | Â | Â | Â | Â |
Widespread Pain Index | x | Â | x | x | x |
Symptom Severity Scale | x | Â | x | x | x |
Participant Global Assessment | x | Â | x | x | x |
Pittsburgh Sleep Quality Index | x | Â | x | x | x |
Patients’ Global fibromyalgia Severity | x |  | x | x | x |
SF-36 | x | Â | x | x | x |
Beck II Depression Inventory | x | Â | x | x | x |
Perceived Stress Scale | x | Â | x | x | x |
Chronic Pain Self-Efficacy | x | Â | x | x | x |
Social Support Survey | x | Â | x | x | x |
Coping Strategies Questionnaire | x | Â | x | x | x |
MOS Social Support Survey | x | Â | x | x | x |
OES for exercise | x | Â | x | x | x |
OES for Tai Chi/AE | Â | x | Â | Â | Â |
PROMISb | x | Â | x | x | x |
Health Assessment Questionnaire | x | Â | x | x | x |
NEO Five-Factor Inventoryc | x | Â | x | x | x |
Five Facet Mindfulness | x | Â | x | x | x |
Credibility-Expectancyd | x | Â | Â | x | x |
Pre-clinical disability | x | Â | x | x | x |
The Hospital Anxiety and Depression Scale | x | Â | x | x | x |
CHAMPS activities | x | Â | x | x | x |
Functional Performance Testse | x | Â | x | x | x |
Body mass index | x | Â | x | x | x |
Medications | x | Â | x | x | x |
Adverse events | x | x | Â | Â | Â |
Adherence | x | x | x | x | x |